MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 47 filers reported holding MEI PHARMA INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $7,000 | -22.2% | 5,118 | 0.0% | 0.00% | – |
| Q3 2016 | $9,000 | +28.6% | 5,118 | 0.0% | 0.00% | – |
| Q2 2016 | $7,000 | 0.0% | 5,118 | -9.1% | 0.00% | – |
| Q1 2016 | $7,000 | -22.2% | 5,628 | 0.0% | 0.00% | – |
| Q4 2015 | $9,000 | +12.5% | 5,628 | +10.9% | 0.00% | – |
| Q3 2015 | $8,000 | -11.1% | 5,076 | 0.0% | 0.00% | – |
| Q2 2015 | $9,000 | +12.5% | 5,076 | +12.8% | 0.00% | – |
| Q1 2015 | $8,000 | -55.6% | 4,499 | +3.9% | 0.00% | – |
| Q4 2014 | $18,000 | -14.3% | 4,332 | +42.9% | 0.00% | – |
| Q3 2014 | $21,000 | +10.5% | 3,032 | +3.8% | 0.00% | – |
| Q2 2014 | $19,000 | -94.9% | 2,921 | -91.3% | 0.00% | -100.0% |
| Q1 2014 | $372,000 | +44.7% | 33,418 | +4.1% | 0.00% | – |
| Q4 2013 | $257,000 | -14.9% | 32,107 | +19.7% | 0.00% | – |
| Q3 2013 | $302,000 | +75.6% | 26,831 | +11.4% | 0.00% | – |
| Q2 2013 | $172,000 | – | 24,084 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anson Funds Management LP | 4,610,423 | $1,782,000 | 0.21% |
| DAFNA Capital Management LLC | 1,767,146 | $683,000 | 0.18% |
| NEA Management Company, LLC | 8,533,072 | $3,299,000 | 0.16% |
| Boxer Capital, LLC | 2,913,091 | $1,126,000 | 0.06% |
| BVF INC/IL | 3,532,057 | $1,365,000 | 0.06% |
| Investmark Advisory Group LLC | 136,000 | $52,000 | 0.05% |
| CARLSON CAPITAL L P | 1,150,000 | $445,000 | 0.03% |
| Artal Group S.A. | 1,000,000 | $387,000 | 0.02% |
| Annandale Capital, LLC | 100,000 | $39,000 | 0.01% |
| Sigma Planning Corp | 641,050 | $248,000 | 0.01% |